MedTrace Logo

A Clinical Trial to Compare the Pharmacokinetic and Safety of CKD-828 20/1.25mg

NCT05881707 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2023-10-31

No results posted yet for this study

Summary

A clinical trial to compare the pharmacokinetic and safety of CKD-828 20/1.25mg

Conditions

Interventions

DRUG

CKD-828, D064, D702

QD, PO

Sponsors & Collaborators

  • Chong Kun Dang Pharmaceutical

    lead INDUSTRY

Principal Investigators

  • Mingul Kim, Ph.D · Jeonbuk National University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Max Age
54 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-07-04
Primary Completion
2023-09-02
Completion
2023-09-27

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05881707 on ClinicalTrials.gov